Verastem Oncology (NASDAQ:VSTM) announced on Wednesday that the U.S. FDA has cleared the investigational new drug application ...

Groundbreaking longevity research initiative brings together leading scientists and institutions to decode the genetic basis ...

Protagonist Therapeutics, Inc. (”Protagonist” or the “Company”) announced that an abstract was accepted for presentation at the Plenary Session at the American Society of Clinical Oncology (ASCO) ...

Vera Therapeutics, Inc.’s VERA share price has surged by 6.17%, which has investors questioning if this is right time to sell.

STATEN ISLAND, N.Y. -- While the Seaview Avenue redesign — officially unveiled by the city earlier this month — was met with ...

Nail fungus can be a persistent and distressing condition, affecting both the aesthetic appeal of your nails and your overall ...